| pubmed-article:17608842 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17608842 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17608842 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:17608842 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17608842 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:17608842 | lifeskim:mentions | umls-concept:C0010346 | lld:lifeskim |
| pubmed-article:17608842 | lifeskim:mentions | umls-concept:C0055856 | lld:lifeskim |
| pubmed-article:17608842 | lifeskim:mentions | umls-concept:C1709323 | lld:lifeskim |
| pubmed-article:17608842 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:17608842 | pubmed:dateCreated | 2007-7-4 | lld:pubmed |
| pubmed-article:17608842 | pubmed:abstractText | The pathogenesis of Crohn's disease is unclear, but many studies suggest that luminal bacteria play an important role in chronic intestinal inflammation in patients with this condition. Clarithromycin is a macrolide antibiotic with immunomodulatory activity. The aim of this study was to evaluate the effect of clarithromycin therapy in Japanese patients with Crohn's disease. | lld:pubmed |
| pubmed-article:17608842 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17608842 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17608842 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17608842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17608842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17608842 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17608842 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17608842 | pubmed:issn | 0815-9319 | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:KitamuraHiros... | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:ChibaTsutomuT | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:NakaseHiroshi... | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:TamakiHiroyuk... | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:MatsuuraMinor... | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:UenoSatoruS | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:KasaharaKatsu... | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:InoueSatokoS | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:UzaNorimitsuN | lld:pubmed |
| pubmed-article:17608842 | pubmed:author | pubmed-author:MikamiSakaeS | lld:pubmed |
| pubmed-article:17608842 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17608842 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:17608842 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17608842 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17608842 | pubmed:pagination | 984-8 | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:meshHeading | pubmed-meshheading:17608842... | lld:pubmed |
| pubmed-article:17608842 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17608842 | pubmed:articleTitle | Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease. | lld:pubmed |
| pubmed-article:17608842 | pubmed:affiliation | Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. | lld:pubmed |
| pubmed-article:17608842 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17608842 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:17608842 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
